HPLC purity
Reverse-phase HPLC with UV detection; ≥99% area-purity target on each production lot.
PeptiOEM · Catalog · Thymosin Alpha-1
Immune modulation · Engine 1 (worldwide)
Lyophilized Thymosin Alpha-1 (Tα-1) for longevity clinics, med spas, 503A compounding pharmacies, and private-label brand owners. 99%+ HPLC purity, per-batch COA + MS. Studied for immune modulation and antiviral research.
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Thymosin Alpha-1 (Tα-1) |
|---|---|
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Molecular weight | ≈ 3108.3 g/mol |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg (custom on request) |
| Documentation | COA + HPLC + MS, per-batch lot file |
| Storage | 2–8 °C protected from light; long-term −20 °C |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Tα-1 is N-terminally acetylated and supplied as the free-acid form unless specified otherwise. Confirm if your protocol requires a different terminal modification.
Documentation
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
Reverse-phase HPLC with UV detection; ≥99% area-purity target on each production lot.
Mass spectrometry identity confirmation against the Thymosin α-1 reference profile.
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Thymosin Alpha-1 (Tα-1) is a 28-amino-acid N-terminally acetylated peptide studied for immune modulation and antiviral pathways. Longevity clinics and 503A pharmacies source Tα-1 for individualized protocols.
Sample lots from 50 vials; production lots from 200 vials with tier pricing.
Yes — 503A pharmacies receive context-specific documentation for compounds outside the FDA's 2026 503B bulks restriction.
Yes — neutral or branded vial label, carton, and document pack via the OEM service path.
Yes. Every lot ships with COA + HPLC + MS document pack and lot traceability.
Related compounds